Literature DB >> 26921961

Production of Recombinant Chemokines and Validation of Refolding.

Christopher T Veldkamp1, Chad A Koplinski2, Davin R Jensen2, Francis C Peterson2, Kaitlin M Smits3, Brittney L Smith3, Scott K Johnson4, Christina Lettieri5, Wallace G Buchholz4, Joyce C Solheim3, Brian F Volkman2.   

Abstract

The diverse roles of chemokines in normal immune function and many human diseases have motivated numerous investigations into the structure and function of this family of proteins. Recombinant chemokines are often used to study how chemokines coordinate the trafficking of immune cells in various biological contexts. A reliable source of biologically active protein is vital for any in vitro or in vivo functional analysis. In this chapter, we describe a general method for the production of recombinant chemokines and robust techniques for efficient refolding that ensure consistently high biological activity. Considerations for initiating development of protocols consistent with Current Good Manufacturing Practices (cGMPs) to produce biologically active chemokines suitable for use in clinical trials are also discussed.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemokine; Chemokine oxidation; Chemokine purification; Chemokine refolding; Expression; Mass spectrometry; Mass spectrometry of chemokines; NMR; Protein; Protein NMR; Protein folding; Purification; Recombinant chemokines; Recombinant cytokines; Refolding; cGMP

Mesh:

Substances:

Year:  2015        PMID: 26921961      PMCID: PMC4811038          DOI: 10.1016/bs.mie.2015.09.031

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  39 in total

1.  Expression of chemokines in Escherichia coli.

Authors:  M D Edgerton; L O Gerlach; T P Boesen; B Allet
Journal:  Methods Mol Biol       Date:  2000

2.  Purification of recombinant chemokines from E. coli.

Authors:  A E Proudfoot; F Borlat
Journal:  Methods Mol Biol       Date:  2000

3.  Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity.

Authors:  Maria De La Luz Sierra; Fuquan Yang; Masashi Narazaki; Ombretta Salvucci; David Davis; Robert Yarchoan; Hongwei H Zhang; Henry Fales; Giovanna Tosato
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

4.  The human cytokine I-309 is a monocyte chemoattractant.

Authors:  M D Miller; M S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

5.  Amino-terminal processing of chemokine ENA-78 regulates biological activity.

Authors:  O Nufer; M Corbett; A Walz
Journal:  Biochemistry       Date:  1999-01-12       Impact factor: 3.162

6.  Structure-function analysis of CCL28 in the development of post-viral asthma.

Authors:  Monica A Thomas; Becky J Buelow; Amanda M Nevins; Stephanie E Jones; Francis C Peterson; Rebekah L Gundry; Mitchell H Grayson; Brian F Volkman
Journal:  J Biol Chem       Date:  2015-01-02       Impact factor: 5.157

7.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 8.  Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.

Authors:  Irina Kufareva; Catherina L Salanga; Tracy M Handel
Journal:  Immunol Cell Biol       Date:  2015-02-24       Impact factor: 5.126

9.  Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor.

Authors:  K Neote; D DiGregorio; J Y Mak; R Horuk; T J Schall
Journal:  Cell       Date:  1993-02-12       Impact factor: 41.582

10.  Cytokine treatment in cancer immunotherapy.

Authors:  Michele Ardolino; Joy Hsu; David H Raulet
Journal:  Oncotarget       Date:  2015-08-14
View more
  13 in total

1.  The dimeric form of CXCL12 binds to atypical chemokine receptor 1.

Authors:  Julia C Gutjahr; Kyler S Crawford; Davin R Jensen; Prachi Naik; Francis C Peterson; Guerric P B Samson; Daniel F Legler; Johan Duchene; Christopher T Veldkamp; Antal Rot; Brian F Volkman
Journal:  Sci Signal       Date:  2021-08-17       Impact factor: 9.517

2.  Structural Insights into Molecular Recognition by Human Chemokine CCL19.

Authors:  Eric M Lewandowski; Kyle G Kroeck; Lian M C Jacobs; Tyler G Fenske; Robin N Witt; Alyssa M Hintz; Elizabeth R Ramsden; Xiujun Zhang; Francis Peterson; Brian F Volkman; Christopher T Veldkamp; Yu Chen
Journal:  Biochemistry       Date:  2022-02-14       Impact factor: 3.321

3.  Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.

Authors:  Austin J Barmore; Sally M Castex; Brittany A Gouletas; Alex J Griffith; Slater W Metz; Nicolas G Muelder; Michael J Populin; David M Sackett; Abigail M Schuster; Christopher T Veldkamp
Journal:  Biochem Biophys Res Commun       Date:  2016-06-21       Impact factor: 3.575

4.  Structural Features of an Extended C-Terminal Tail Modulate the Function of the Chemokine CCL21.

Authors:  Natasha A Moussouras; Gertrud M Hjortø; Francis C Peterson; Martyna Szpakowska; Andy Chevigné; Mette M Rosenkilde; Brian F Volkman; Michael B Dwinell
Journal:  Biochemistry       Date:  2020-03-26       Impact factor: 3.162

5.  CCR7 Sulfotyrosine Enhances CCL21 Binding.

Authors:  Andrew J Phillips; Deni Taleski; Chad A Koplinski; Anthony E Getschman; Natasha A Moussouras; Amanda M Richard; Francis C Peterson; Michael B Dwinell; Brian F Volkman; Richard J Payne; Christopher T Veldkamp
Journal:  Int J Mol Sci       Date:  2017-08-25       Impact factor: 5.923

6.  Functional expression of CCL8 and its interaction with chemokine receptor CCR3.

Authors:  Baosheng Ge; Jiqiang Li; Zhijin Wei; Tingting Sun; Yanzhuo Song; Naseer Ullah Khan
Journal:  BMC Immunol       Date:  2017-12-28       Impact factor: 3.615

7.  Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.

Authors:  You-Hong Cheng; Jonathan M Eby; Heather M LaPorte; Brian F Volkman; Matthias Majetschak
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

8.  Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.

Authors:  Vladimir Purvanov; Christoph Matti; Guerric P B Samson; Ilona Kindinger; Daniel F Legler
Journal:  Int J Mol Sci       Date:  2018-12-04       Impact factor: 5.923

9.  Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.

Authors:  Astrid S Jørgensen; Olav Larsen; Edith Uetz-von Allmen; Michael Lückmann; Daniel F Legler; Thomas M Frimurer; Christopher T Veldkamp; Gertrud M Hjortø; Mette M Rosenkilde
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

10.  Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.

Authors:  Natasha A Moussouras; Anthony E Getschman; Emily R Lackner; Christopher T Veldkamp; Michael B Dwinell; Brian F Volkman
Journal:  Int J Mol Sci       Date:  2017-09-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.